Subdural Hematoma: Clinical Trials

2 trials for Subdural Hematoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1

Follow Subdural Hematoma: new trials by email Literature Review of Subdural Hematoma trials Research Report on Subdural Hematoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma
Tranexamic acid (TXA), Placebo - Subdural Hematoma
Phase 3RecruitingUnity Health Toronto1302026-05-202026-05-29
Start or STop Anticoagulants Randomised Trial (SoSTART)
Apixaban, Rivaroxaban, Edoxaban - Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive
Phase 3CompletedUniversity of Edinburgh2032018-03-282022-04-08

Narrower conditions

Hematoma, Subdural (2)  ·  Atrial Fibrillation (1)  ·  Atrial Flutter (1)  ·  Cerebral Small Vessel Diseases (1)  ·  Intracranial Hemorrhage, Hypertensive (1)  ·  Intracranial Hemorrhages (1)  ·  Subarachnoid Hemorrhage (1)

Broader conditions

Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Craniocerebral Trauma (2)  ·  Hematoma (2)  ·  Hemorrhage (2)  ·  Intracranial Hemorrhage, Traumatic (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Trauma, Nervous System (2)  ·  Vascular Diseases (2)  ·  Wounds and Injuries (2)  ·  Arrhythmias, Cardiac (1)

Interventions

Acenocoumarol (1)  ·  Dabigatran (1)  ·  Phenindione (1)  ·  Rivaroxaban (1)  ·  Tranexamic Acid (1)  ·  Warfarin (1)  ·  apixaban (1)  ·  edoxaban (1)

Sponsors

Unity Health Toronto (1)  ·  University of Edinburgh (1)

Countries

Canada (1)  ·  United Kingdom (1)

Top investigators

Michael D Cusimano, MD, PhD (1)  ·  Rustam Al-Shahi Salman, MA PhD FRCP (1)

Results publications

PMID 34022170, PMID 34487722, PMID 36700520

NIH funding

2016 (1)